The development of the adult respiratory distress syndrome (ARDS) in t
he critically ill patient is associated with a significant morbidity a
nd mortality. The pulmonary dysfunction in ARDS is largely secondary t
o neutrophil-mediated oxidant injury. The purpose of these studies is
to examine the effect of the antioxidant N-acetyl cysteine (NAC) on a
rodent model of lung injury. We postulated that NAC might attenuate lu
ng injury following intratracheal challenge with endotoxin (lipopolysa
ccharide; LPS). Male Sprague-Dawley rats were administered NAC systemi
cally either before or after intratracheal administration of LPS. Lung
injury was assessed by measuring the transpulmonary leakage of I-125-
labeled albumin, pulmonary myeloperoxidase content, bronchoalveolar la
vage fluid cell counts, pulmonary lipid peroxidation and histology. NA
C administration significantly attenuated the LPS-induced increases in
lung permeability (LPS: .24 +/- .08 vs. LPS + NAG: .12 +/- .03, p < .
05) and reduced the LPS-dependent increase in lipid peroxidation. Howe
ver, total and differential bronchoalveolar lavage cell counts and mye
loperoxidase content were not affected by-NAC pretreatment. Although n
eutrophil influx was unaffected, neutrophil activation as assessed by
surface CD11b expression and chemiluminescence was significantly downr
egulated by NAG. Importantly, NAC administration up to 2 h after endot
oxin challenge was still able to significantly ameliorate LPS-induced
lung injury. Our data suggests that the attenuation of acute lung inju
ry by NAC in our rodent model is related to free radical scavenging an
d inhibition of the neutrophil oxidative burst, rather than by an effe
ct on inflammatory cell migration. These results suggest novel approac
hes for therapeutic interventions in acute lung injury.